Updated:
Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust was established in 1999 and began active grantmaking in 2008 after Leona Helmsley's death.
Helmsley Charitable Trust
The Leona M. and Harry B. Helmsley Charitable Trust was established in 1999 and began active grantmaking in 2008 after Leona Helmsley's death. The endowment originated from the Helmsley real estate holdings, including prior interests in the Empire State Building and Park Lane Hotel that were liquidated to fund operations. Trustees include grandsons David Panzirer and Walter Panzirer along with longtime counsel Sandor Frankel. The trust allocates 38.46 percent of assets to private equity and maintains commitments to Sequoia Capital U.S. Venture Fund XIV, Western Technology Investment Fund IX, and OrbiMed Advisors. It also holds program-related investments in TIXiMED and StartUp Health while participating as a limited partner in the T1D Fund alongside Breakthrough T1D. Geographic reach covers the United States and Israel through dedicated program areas, with additional exposure in Sub-Saharan Africa via grants and co-investments. The organization employs 120 professionals at its New York headquarters. Josh Fenton was appointed Chief Investment Officer in 2024. Adjacent vehicles include the core trust itself and historical holdings such as a Gulfstream IV previously operated by Helmsley Enterprises. The trust maintains memberships in the Health Research Alliance and PEAK Grantmaking. Governance separates investment decisions from grantmaking through a dedicated CIO role reporting to the trustees. This architecture allows the endowment to pursue both traditional fund commitments and direct program-related investments without a separate family office entity managing personal wealth.
General information
Firm type
Endowment / Foundation
Year founded
1999
Location
Region
North America
Country
United States
City
New York
Corporate office
230 Park Avenue Suite 659, New York, NY 10169, United States
Principals
Sandor Frankel
Trustee
David Panzirer
Trustee
Walter Panzirer
Trustee
Altss tracks 1 additional named team member for this firm — including direct investment leads, IR, and operating principals not listed on the public website.
Book a demoSector focus
Frequently asked questions
Who runs investment decisions at the Helmsley Charitable Trust?
Josh Fenton serves as Chief Investment Officer and oversees asset allocation and external manager relationships. Trustees including Sandor Frankel, David Panzirer, and Walter Panzirer retain final authority on major commitments.
Does the Helmsley Charitable Trust participate in fund commitments or only direct deals?
The trust acts as a limited partner in multiple venture and private equity funds, including Sequoia Capital U.S. Venture Fund XIV and OrbiMed Advisors. It also executes program-related investments directly in companies such as TIXiMED.
Where does the underlying wealth come from?
The endowment was funded by liquidation of assets from the Helmsley real estate empire built by Leona M. and Harry B. Helmsley.
What investment stages does the Helmsley Charitable Trust typically target?
Commitments span early-stage venture through growth equity via fund investments and select direct holdings. Program-related investments focus on companies aligned with medical research mandates.
How is the Helmsley Charitable Trust related to Breakthrough T1D?
The trust maintains a strategic partnership with Breakthrough T1D through the T1D Fund, serving as a limited partner in that vehicle.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: